NF119: A Phase 2, Open-Label, Single Arm, Non-Controlled, Single-Stage Study to Evaluate the Safety and Effects of HLX-1502 in Patients with Plexiform Neurofibroma and Neurofibromatosis Type 1
| Protocol No. | PHO-DOD-NF119 | Scope | National |
|---|---|---|---|
| Principal Investigator | Steven Rhodes | Treatment Type | Treatment |
| Age Group | Adults and Children | Phase | Phase II |
